Ixabepilone (epothilone B analogue BMS-247550) is active in chemotherapy-naive patients with hormone-refractory prostate cancer: a Southwest Oncology Group trial S0111. (Q33369363)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Ixabepilone (epothilone B analogue BMS-247550) is active in chemotherapy-naive patients with hormone-refractory prostate cancer: a Southwest Oncology Group trial S0111. |
scientific article |
Statements
1 reference
Ixabepilone (epothilone B analogue BMS-247550) is active in chemotherapy-naive patients with hormone-refractory prostate cancer: a Southwest Oncology Group trial S0111. (English)
1 reference
Southwest Oncology Group
1 reference
Catherine M Tangen
1 reference
Maha Hussain
1 reference
Primo N Lara
1 reference
Ulka N Vaishampayan
1 reference
Daniel P Petrylak
1 reference
A Dimitrios Colevas
1 reference
Wael A Sakr
1 reference
E David Crawford
1 reference
1 December 2005
1 reference
1 reference
23
1 reference
34
1 reference
8724-8729
1 reference
Identifiers
1 reference
1 reference